Christopher received dual B.S. degrees in Medical Biology and Health Psychology from MCPHS in 2015. He then received an M.S. degree in Physiology and Biophysics from Georgetown University in 2016, and an M.B.A. degree in Healthcare Management from MCPHS in 2022. Chris joined MGH in 2016 as part of the Integrated Brain Health Clinical and Research Program with Dr. Ana-Maria Vranceanu. In his role, he coordinated studies developing telehealth-based behavioral treatments for patients with physical and psychiatric comorbidities. In 2018, he joined the Laboratory of Neuropsychiatry and Neuromodulation with Dr. Joan Camprodon. In his role, he coordinated neuroimaging studies investigating biomarkers and predictors of response to neuromodulation treatments. Additionally, he treated patients in the Transcranial Magnetic Stimulation Clinical Service. As of 2021, Chris has been working as the Program Manager for the Division of Neuropsychiatry and Neuromodulation. In his role, he oversees all administrative, clinical, research, and educational operations of the division. Chris is interested in the intersection of mental health and technology with emphasis on improving accessibility to neuropsychiatric treatments in underserved and disadvantaged populations.